Otezla 30 MG tab 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUJS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,336
Award facts
- Contract value 100% obligated
- $24,336.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,336.27 delivery order to AmerSourceBergen Drug Corp (parent company: Cencora, Inc.) on January 27, 2026, for the supply of Otezla 30 mg tablets in quantities of 60 units. The contract employs firm fixed-price pricing with no set-aside designation, indicating full and open competition. Performance will be completed by February 24, 2026, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the company's primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying a diverse range of prescription medications, generic drugs, vaccines, and medical devices to military and veteran healthcare systems. Otezla is an immunosuppressant medication used primarily for treating autoimmune conditions such as psoriasis and psoriatic arthritis, representing the type of specialty pharmaceutical product the company routinely delivers through its extensive federal contract portfolio. The company's demonstrated capability to fulfill government medical procurement requirements through competitive awards, combined with its parent company Cencora's significant presence across multiple federal agencies, positions AmerSourceBergen as a key supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FAUJS?
SPE2DR26FAUJS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FAUJS worth?
The government has obligated $24,336 on SPE2DR26FAUJS.
Is contract SPE2DR26FAUJS an order under another contract?
Yes. SPE2DR26FAUJS is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUJS competed?
The extent of competition for SPE2DR26FAUJS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award